mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.08 |
0.6 |